CD44 activation enhances acute monoblastic leukemia cell survival via Mcl-1 upregulation

Leukemia Research

Volumn 36, Issue 3, 2012, Pages 358-362

  Sansonetti, Arnaud ^a   Bourcier, Sébastien ^a   Durand, Laetitia ^a   Chomienne, Christine ^a   Smadja Joffe, Florence ^a   Robert Lézénès, Jacqueline ^a  

^a INSERM   (France)

Author keywords

Acute monoblastic leukemia; AML; Apoptosis resistance; CD44; Mcl 1; Survival; THP 1

Indexed keywords

HERMES ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN BCL XL; PROTEIN MCL 1; SMALL INTERFERING RNA;

ACUTE MONOCYTIC LEUKEMIA; ANTIGEN FUNCTION; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; APOPTOSIS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84855951592     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.09.022     Document Type: Article

References (42)

1. Konopleva M.Y., Jordan C.T. Leukemia stem cells and microenvironment: biology and therapeutic targeting. J Clin Oncol 2011, 29:591-599.
2. Ayala F., Dewar R., Kieran M., Kalluri R. Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 2009, 23:2233-2241.
3. Westhoff M.-A., Fulda S. Adhesion-mediated apoptosis resistance in cancer. Drug Resist Updates 2009, 12:127-136.
4. Konoplova M., Konoplev S., Hu W., Zaritskey A.Y., Afanasiev B.V., Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 2002, 16:1713-1724.
5. Garrido S.M., Appelbaum F.R., Willman C.L., Banker D.E. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with human bone marrow stromal cell line (HS-5). Exp Hematol 2001, 29:448-457.
6. Tabe Y., Jin L., Tsutsumi-Ishii Y., Xu Y., McQueen T., Priebe W., et al. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res 2007, 67:684-694.
7. Hall B.M., Gibson L.F. Regulation of lymphoid and myeloid leukemic cell survival: role of stromal cell adhesion molecules. Leuk Lymphoma 2004, 45:35-48.
8. Legras S., Günthert U., Stauder R., Curt F., Oliferenko S., Kluin-Nelemans H.C., et al. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood 1998, 91:3401-3413.
9. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980, 26:171-176.
10. Morimoto K., Robin E., Le Bousse-Kerdiles M.C., Li Y., Clay D., Jasmin C., et al. CD44 mediates hyaluronan binding by human myeloid KG1a and KG1 cells. Blood 1994, 83:657-662.
11. Gahdoum Z., Delaunay J., Maquarre E., Durand L., Lancereaux V., Qi J., et al. The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells. Leuk Lymphoma 2004, 45:1501-1510.
12. Bourcier S., Sansonetti A., Durand L., Chomienne C., Robert-Lézénés J., Smadja-Joffe F. CD44-ligation induces, through ERK1/2 pathway, synthesis of cytokines TNF-α and IL-6 required for differentiation of THP-1 monoblastic leukemia cells. Leukemia 2010, 24:1372-1375.
13. Testa U., Riccioni R. Deregulation of apoptosis in acute myeloid leukemia. Haematologica 2007, 92:81-94.
14. Campos L., Rouault J.-P., Sabido O., Oriol P., Roubi N., Vasselon C., et al. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993, 81:3091-3096.
15. Konopleva M., Zhao S., Hu W., Jiang S., Snell V., Weidner D., et al. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are overexpressed and contribute to chemoresistance of no-proliferating leukaemic CD34+ cells. Br J Haematol 2002, 118:521-534.
16. Bragintseva K., Geisenhof S., Kern R., Eichenlaub S., Reindl C., Elwart J.W., et al. FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-X(L). Blood 2005, 105:3679-3685.
17. Kaufmann S.H., Karp J.E., Svingen P.A., Krajewski S., Burke P.J., Gore S.D., et al. Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood 1998, 91:991-1000.
18. Yoshimoto G., Miyamoto T., Jabbarzadeh-Tabrizi S., Iino T., Rocnik J.L., Kikushige Y., et al. FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation. Blood 2009, 114:5034-5043.
19. Charrad R.S., Li Y., Delpech B., Balitrand N., Clay D., Jasmin C., et al. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med 1999, 5:669-676.
20. L is required for heme synthesis during the chemical induction of erythroid differentiation of murine erythroleukemia cells independently of its anti-apoptotic function. Blood 2003, 101:2575-2583.
21. Del Poeta G., Venditti A., Del Principe M.I., Maurillo L., Buccisano F., Tamburini A., et al. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood 2003, 101:2125-2531.
22. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003, 4:33-45.
23. Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?. Nat Rev Cancer 2011, 11:254-267.
24. Müller-Sieburg C.E., Deryugina E., Khaldoyanidi S., O'Rourke A. Tissue- and epitope-specific mechanisms account for the diverse effects of anti-CD44 antibodies on the maintenance of primitive hematopoietic progenitors in vitro. Blood Cells Mol Dis 2000, 26:291-302.
25. Allouche M., Charrad R.S., Bettaieb A., Greenland C., Grignon C., Smadja-Joffe F. Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells. Blood 2000, 96:1187-1190.
26. Maquarre E., Artus C., Gadhoum Z., Jasmin C., Smadja-Joffe F., Robert-Lézénès J. CD44 ligation induces apoptosis via caspase- and serine protease-dependent pathways in acute promyelocytic leukemia cells. Leukemia 2005, 19:2296-2303.
27. Artus C., Maquarre E., Moubarak R.S., Delettre C., Jasmin C., Susin S.A., et al. CD44 ligation induces caspase-independent cell death via a novel calpain/AIF pathway in human erythroleukemia cells. Oncogene 2006, 25:5741-5751.
28. Ohwada C., Nakaseko C., Koizumi M., Takeuchi M., Ozawa S., Naito M., et al. CD44 and hyaluronan engagement promotes dexamethasone resistance in human myeloma cells. Eur J Haematol 2008, 80:245-250.
29. Chen C., Chang M.-C., Hsieh R.-K., Chang Y.-F., Lin J., Tsan K.-W. Activation of CD44 facilitates DNA repair in T-cell lymphoma but has differential effects on apoptosis induced by chemotherapeutic agents and ionizing radiation. Leuk Lymphoma 2005, 46:1785-1795.
30. Bates R.C., Edwards N.S., Burns G.F., Fisher D.E. A CD44 survival pathway triggers chemoresistance via lyn kinase and phoshoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res 2001, 61:5275-5283.
31. Yu Q., Toole B.P., Stamenkovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 1997, 186:1985-1996.
32. Wang S.J., Bourguignon L.H. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg 2006, 132:771-778.
33. Lee J.-L., Wang M.-J., Sudhir P.-R., Chen J.-Y. CD44 engagement promotes matrix-derived survival through the CD44-Src-integrin axis in lipid rafts. Mol Cell Biol 2008, 28:5710-5723.
34. Fujita Y., Kitagawa M., Nakamura S., Azuma K., Ishii G., Higashi M., et al. CD44 signaling through focal adhesion kinase and its anti-apoptotic effect. FEBS Lett 2002, 528:101-108.
35. Opferman J.T., Iwasaki H., Ong C.C., Suh H., Mizuno S.-I., Akashi K., et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005, 307:1101-1104.
36. Charrad R.S., Gadhoum Z., Glachant Q.I.J., Allouche A., Jasminc M., et al. effects of anti-cd44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 2002, 99:290-299.
37. Delaunay J., Lecomte N., Bourcier S., Qi J., Gadhoum Z., Durand L., et al. Contribution of GM-CSF and IL-8 to the CD44-induced differentiation of acute monoblastic leukemia. Leukemia 2008, 22:873-876.
38. Altucci L., Rossin A., Raffelsberger W., Reitmair A., Chomienne C., Gronemeyer H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med 2001, 7:680-686.
39. Sordet O., Bettaieb A., Bruey J.-M., Eymin B., Droin N., Ivarsson M., et al. Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. Cell Death Differ 1999, 6:351-361.
40. Xu H.M., Tepper C.G., Jones J.B., Fernandez C.E., Studzinski G.P. 1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp Cell Res 1993, 209:367-374.
41. L and XIAP in the prolonged survival of monocytic cells. Leukemia 2003, 17:390-400.
42. Warr M.R., Shore G.C. Unique biology of Mcl-1: therapeutics opportunities in cancer. Curr Mol Med 2008, 8:138-147.